0
Eidos Therapeutics, Inc. Banner Image

Eidos Therapeutics, Inc. has reached its limit for free report views

Work for Eidos Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Eidos Therapeutics, Inc.

  • Ticker EIDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eidos Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Eidos is developing acoramidis, a potentially disease-modifying therapy for the treatment of ATTR.
Eidos Therapeutics, Inc.

Most Recent Annual Report

Eidos Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Eidos Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports